May 13, 2022
Damien McDevitt, Ph.D.
President and CEO
Stories this photo appears in:
BIOTECH: Starting Clinical Trial for Parkinson’s Stem Cell Therapy
San Diego-based Aspen Neuroscience, Inc. announced a Series B financing round of $147.5 million on May 9 to further advance its treatment of Parkinson’s disease using autologous stem cell therapies.